Bioactive Materials Market

The Bioactive Materials Market is valued at USD 2.9 Bn in 2026 and is projected to reach USD 7.3 Bn, growing at a CAGR of 14% by 2033.

Use of Bioactive Materials in Dentistry to Bolster Growth

Growing use of bioactive materials in nanomedicines, mechanical interlocks, and dental and bone tissue healing remains instrumental in driving growth of the market. Repair and regenerative properties of various bioactive materials have increased their application scope in endodontic procedures such as root canals. This aspect coupled with increasing root canal procedures are expected to trigger use of bioactive materials. For instance, according to American Association of Endodontics, more than 41,000 root canal procedures are being performed per day in United States alone, resulting in over 15 million root canal surgeries performed every year. Other cosmetic applications in the dental space such as teeth restoration, tooth re-mineralisation and pulp capping are widening their scope, consecutively aiding the bioactive materials market growth.

Glass Likely to Emerge as a Widely Used Bioactive Material

Demand for bioactive glass has been witnessing an upswing since the recent past and is expected to further increase in the coming years. The growth in demand for bioactive glass can be attributed towards its optimum biocompatibility and bioactivity as an implant material with better bonding abilities within human body. Its higher functionality and compatibility has also fuelled its use in applications such as replacement and repairing of broken or damaged bones, which is expected to drive sales of bioactive glass. In addition, use of bioactive glass in regenerating dental hard tissues particularly on acid affected skin by using phosphate, calcium and other ions has further fuelled its demand. That said, increasing application of bioactive glass is expected to largely contribute towards value growth of the bioactive materials market on the global front.

North America Likely to Reign Supreme; Bioactive Materials Market in Asia Pacific Projected to Grow at a Significant Pace

Better healthcare infrastructure, stable growth in GDP per capita and growing investments in medical technology has spurred growth of bioactive materials market in North America. Moreover, demand for bioactive materials has been influenced by growing number of dental and orthopaedic surgeries. According to analysis of World Bank, in United States individuals aged 65 years and above account for about 16.5% of the overall population. This has necessitated efficient medical therapies for gum problems, and tooth decay.

In addition, rising burden of arthritis among aged individuals is another factor that is gaining significant medical attention. As per OECD (Organization for Economic Cooperation and Development), knee replacements stood at around 198.4 per 100,000 individuals in 2020 in Canada, increasing steadily each year owing to growing aged population suffering from arthritis related problems. Moreover, according to AAOS (American Academy of Orthopaedic Surgeons), rising musculoskeletal diseases have resulted in increasing surgeries apropos to joint replacement among developed nations of North America such as Unites States, and Canada. These procedures have fuelled demand for bioactive materials, consequently giving an impetus to the growth of the market in the region.

Alternatively, demand for bioactive materials in emerging economies in Asia Pacific is expected to gain significant momentum in the years to follow. This can be attributed towards increasing cancer cases in the region, influencing need for nanomedicines, in turn bolstering growth of bioactive materials market in the region. For instance, according to National Central Cancer Registry of China, cases of oral cancer in the country are expected to grow at a significant pace in the coming years. As per analysis of BRAT (Biomedical Research and Therapy), oral cancer cases are highest in countries of India and China with a case count of around 77,003 and 21,413 respectively. This aspect is expected to influence use of advanced medical technology, in turn contributing towards growth of the bioactive materials market in Asia Pacific.

Bioactive Materials Market: Competitive Landscape

Key companies in the bioactive materials market are involved in collaborations, partnerships and strategic alliances to strengthen their position. For instance, in 2020, Stryker completed the acquisition of Wright Medical Group NV to enhance its market position. In June 2021, Amasa Therapeutics was granted an option by Lineage Cell Therapeutics Inc to acquire royalty bearing license to use HyStem Technology introduced by Lineage to develop market therapies used in treating solid tumors. Likewise, same year in July, a distribution agreement was signed between Arthrex and Celularity. Under this agreement, biomaterial products of Celularity can be distributed and commercialized by Arthrex particularly for sports medicine and orthopaedics which is placental derived.

A few of the major players in bioactive materials market include:

• Zimmer Biomet Holdings, Inc.
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• Medtronic plc
• B. Braun Melsungen AG
• Corbion N.V.
• Evonik Industries AG
• 3M Company (Biomaterials Division)
• Terumo Corporation
• Cook Medical
• Integra LifeSciences Corporation
• Orthovita, Inc.
• NovaBone Products, LLC
• Bonalive Biomaterials Ltd.
• Biogennix, LLC

The Global Bioactive Materials Market is Segmented as Below:

By Material

• Bioactive Glass
• Bioactive Glass-Ceramics
• Bioactive Ceramics
• Bioactive Composites

By Application

• Dentistry
• Orthopaedics
• Nanomedicines
• Bioengineering
• Others

By Form

• Powder
• Moldable
• Granules
• Others

By Region

• North America
• Europe
• Asia Pacific
• LAMEA